GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
16.2916 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, CNR1, CNR2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
16.2194 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, KCNH2, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, XDH |
16.2095 |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.2095 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.2095 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CES1, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KCNH2, KDR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR |
16.1864 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, CNR1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
13.6336 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SLC6A3, SLC6A4, SRC, TYR |
12.9678 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, KDR, MMP2, PIK3CA, PPARA, PTGS2, RORC, SLC6A3, SLC6A4, SRC, TYR |
12.1805 |
[BP] GO:0099536 |
None
|
CNR1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1, SLC6A2 |
11.7236 |
[BP] GO:0099537 |
None
|
CNR1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1, SLC6A2 |
11.7236 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, PTGS2, SLC6A4 |
11.7064 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, PTGS2, SLC6A4 |
11.7064 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRB, FABP4, GRM1, GRM5, GRM8, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A3, SLC6A4, SRC, TYR |
11.3917 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
11.1701 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FLT3, HSD11B2, HTR1B, HTR5A, PTGS2, RORC, SLC6A3, SLC6A4, SRC, TYR |
10.9031 |
[BP] GO:0007268 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1, SLC6A2 |
10.8297 |
[BP] GO:0098916 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1, SLC6A2 |
10.8297 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KCNH2, KDR, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC |
10.8229 |
[BP] GO:0097756 |
None
|
ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
10.151 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD2, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, PTGS2 |
10.1084 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, PTGS2, RORC, SLC6A4, SRC, TYR |
10.1035 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CES1, CNR1, CNR2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, HTR1B, HTR1D, KDR, SLC6A3, SLC6A4, SRC |
9.77589 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CES1, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR |
9.58167 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
9.10794 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, CNR1, DRD2, DRD3, DRD4, HTR1B, HTR2A, KCNH2, MMP9, PTGS2 |
8.97228 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA2A, CA2, CNR1, CNR2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SRC |
8.94602 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
8.94602 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
8.66778 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
8.62829 |
[BP] GO:0023052 |
None
|
ADORA1, CNR1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, KCNH2, SLC1A1, SLC6A2 |
8.58282 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, BCL2, CNR1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2, SLC1A1, SLC6A2 |
8.53298 |
[BP] GO:0007267 |
None
|
ADORA1, CNR1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1, SLC6A2 |
8.52841 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KCNH2, MET, PIK3CA, PIK3CB, SRC, TERT |
8.44032 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
8.24702 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD3, DRD4, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
8.12786 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, FABP3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS1, PTGS2, SLC6A4, SRC, TERT, XDH |
8.06231 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD3, DRD4, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
8.05295 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
8.04547 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRIK5, GRM1, GRM5, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
7.9231 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KCNH2, MET, PIK3CA, PIK3CB |
7.88816 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B, HTR1E, PPARA |
7.88816 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B, HTR1E, PPARA |
7.83815 |
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B, HTR1E |
7.79178 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
7.79178 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, SLC6A4 |
7.78715 |
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B, HTR1E |
7.66218 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, DRD4, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
7.64861 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FUT7, HTR2B, HTR2C, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
7.63825 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC1A1, SLC6A3, SLC6A4, SRC, TERT, XDH |
7.56722 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2, DRD2, HTR1B |
7.49687 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
7.48899 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.4828 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
7.42598 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC |
7.40527 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AXL, BCL2, CA1, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, RORC, SRC |
7.3957 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, PPARA, PTGS2, SLC6A4, SRC |
7.3925 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C |
7.3584 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.12183 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.12183 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGS2, SLC6A3, SRC, TERT |
7.03729 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.01416 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
6.97698 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA, PTGS2, SLC6A3, SLC6A4, SRC, TYR |
6.93407 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, ESR1, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT |
6.91287 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, GRIK5, GRM5, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
6.91287 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ALOX15, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, GRM5, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, KCNH2, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
6.90014 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CNR1, DRD2, DRD3, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC |
6.90014 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.90014 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, HTR1B, HTR5A, IGF1R, MMP2, PPARA, PTGS2, SLC6A4, SRC |
6.89979 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD2, HTR1B, HTR2A, PTGS2, SLC6A4 |
6.89979 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.88093 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, ESRRB, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.86019 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.759 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.759 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA, PTGS1, PTGS2 |
6.62988 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESRRA, FABP4, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
6.60169 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.60169 |
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B |
6.60169 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.60169 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CNR1, CYP1A1, DRD3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, RORC, SRC |
6.58075 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.49998 |
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B |
6.47445 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, SLC6A3, SLC6A4, SRC, TYR |
6.47445 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.46778 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, HTR1B, IGF1R, KCNH2, KDR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SLC6A4, SRC, TERT |
6.38937 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, CNR1, DRD2, DRD3, DRD4, HTR1B, HTR2A |
6.35454 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, GRIK5, HTR1A, PTGS2, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
6.35335 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, BCL2, CA2, CA7, CNR1, DRD2, DRD3, DRD4, GRM5, HTR1A, HTR1B, HTR2A, KCNH2, MMP9, PTGS2, SLC6A4 |
6.31062 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
6.30466 |
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B |
6.30466 |
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B |
6.30466 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, HTR1A, SLC6A3, TYR |
6.28509 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC |
6.28319 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, NQO2, PTGS1, RORC |
6.28007 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD2, DRD3, HTR2A, HTR2B, HTR2C, KDR, SRC |
6.22397 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD2, DRD3, DRD4, GRM1, GRM5, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, SLC6A3, SLC6A4 |
6.2156 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.20274 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.15011 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, SLC6A3, SLC6A4, SRC, TYR |
5.98817 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, HTR1A, SLC6A3, TYR |
5.92937 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, HTR7, PPARA, RORC, SLC6A4, SRC |
5.88322 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4, PTGS2, SLC6A4 |
5.87364 |
[BP] GO:0051588 |
None
|
DRD2, DRD3, DRD4, GRIK5, HTR1A, HTR1B, HTR2C, SLC6A4 |
5.82947 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, HTR1B, HTR1E, HTR2A, PPARA |
5.72735 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, DRD2, DRD4, FLT3, GRM1, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTPN1, SRC, XDH |
5.68081 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.66668 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CNR1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, SLC6A4, SRC |
5.64521 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.63705 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.63705 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, HTR1B, HTR1E, HTR2A, PPARA |
5.61676 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, HTR2C, KCNH2, PPARA, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
5.52188 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
5.4966 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, GRM1, HSD11B2, HTR1B, HTR2A, HTR2B, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT, TYR |
5.37604 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, HTR1B, IGF1R, KDR, MMP2, PIK3CA, PTGS2, RORC, SLC6A4, SRC |
5.37334 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
5.31583 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.2693 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CNR1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, SLC6A4, SRC |
5.21587 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
5.18939 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC |
5.18809 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.11844 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.11844 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.10055 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
5.08121 |
[BP] GO:0030814 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B, HTR1E |
5.0393 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.0393 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
5.0393 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KCNH2, PIK3CB |
5.01966 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
5.01288 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
5.0008 |
[BP] GO:0050433 |
None
|
ADRA2A, CNR1, DRD2, DRD3, HTR1B, HTR2A |
4.98653 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.93291 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CES1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SLC6A3, SLC6A4, SRC, TERT, TYR |
4.89467 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HTR2A, HTR2B, PIK3CA, PIK3CB, PTPN1, SRC |
4.88197 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, SRC |
4.8779 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
4.87572 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.86445 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.82467 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
4.79104 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR1B, HTR2B |
4.77272 |
[BP] GO:0007200 |
None
|
ADRA2A, DRD2, ESR1, GRM5, HTR2A, HTR2B, HTR2C |
4.72085 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD2, DRD3, DRD4, HTR1A, SLC6A3 |
4.6884 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3, HTR1B, HTR2A |
4.68764 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, XDH |
4.68695 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, FLT3, GRM1, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A3, SRC, TERT, XDH |
4.6851 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, DRD2, DRD4, FLT3, GRM1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, PIK3CB, PTPN1, SRC, XDH |
4.66634 |
[BP] GO:2001023 |
None
|
CNR1, DRD2, DRD3, DRD4, HTR1B, HTR2A, MET |
4.66634 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HTR2A, HTR2B, PIK3CA, PIK3CB, PTPN1, SRC |
4.58293 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.5443 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KCNH2, PIK3CB |
4.53393 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2, SLC6A3, TERT |
4.51948 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
4.51773 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HTR2A, HTR2B, IGF1R, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
4.49133 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, DRD3, HTR1B, SLC6A3 |
4.48371 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.48371 |
[BP] GO:0030799 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B, HTR1E |
4.45951 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
4.45951 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA, PTGS1, PTGS2 |
4.4582 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, CNR1, CNR2, DRD4, GRIA2, GRIA4, GRIK5, GRM5, KCNH2, KDR, SRC |
4.45036 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, BCL2, CNR2, DRD2, DRD3, ESR1, ESR2, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
4.45036 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
4.45036 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, BCL2, CNR2, DRD2, DRD3, ESR1, ESR2, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
4.4326 |
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
4.4326 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, HTR2A, HTR2B, HTR2C, SRC |
4.43015 |
[BP] GO:0030817 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B |
4.42543 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.40477 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.40477 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR, XDH |
4.37719 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, DRD4, FLT3, GRM1, HTR2A, HTR2B, PIK3CB, PTPN1, SRC |
4.37719 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.37542 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR1B, HTR2A |
4.37542 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR1B, IGF1R, KCNH2, KDR, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT |
4.35354 |
[BP] GO:0008217 |
None
|
ADORA1, CNR1, DRD2, DRD3, HSD11B2, PPARA, PTGS1, PTGS2 |
4.33676 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
4.33562 |
[BP] GO:0031280 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
4.32325 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DRD4, FLT3, GRM1, HTR2A, HTR2B, IGF1R, PIK3CB, PTPN1, SRC |
4.3043 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ALOX15, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
4.29933 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HTR2A, HTR2B, PIK3CA, PIK3CB, PTPN1, SRC |
4.243 |
[BP] GO:0051350 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
4.20523 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, TYR, XDH |
4.20523 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
4.19666 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.17523 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.14753 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, BCL2, CNR1, CNR2, CYP19A1, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A3, SRC, TERT, XDH |
4.07275 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.0493 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, SLC6A3 |
4.04437 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.04329 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
4.04171 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC |
4.02084 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA2A, ALOX15, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
3.98499 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KCNH2, PIK3CB |
3.96709 |
[BP] GO:0030802 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B |
3.91208 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
3.90732 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2, TERT |
3.89469 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, DRD3, PPARA |
3.89469 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.8818 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB |
3.86718 |
[BP] GO:0060078 |
None
|
ADORA1, DRD4, GRIA2, GRIA4, GRIK5, GRM5 |
3.86718 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
3.86293 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.85294 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.85294 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, XDH |
3.83056 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
3.82517 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
3.81891 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
3.79987 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
3.79987 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.79987 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.79987 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.79987 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2, HTR1B |
3.79987 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.79987 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, HTR2B, KCNH2, MMP12, PTGS2, SLC6A4, SRC, TERT |
3.79334 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4, HTR2A |
3.78659 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, TYR, XDH |
3.78659 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.78659 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
3.78061 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB |
3.77172 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB |
3.76247 |
[BP] GO:1900371 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B |
3.72618 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB |
3.72351 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, DRD4, KCNH2, MMP9 |
3.71604 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.7116 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.7116 |
[BP] GO:0030808 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3, GRM8, HTR1B |
3.7116 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB |
3.65869 |
[BP] GO:0006939 |
None
|
DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
3.65601 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9, TERT |
3.63492 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, BCL2, CNR1, DRD2, DRD3, DRD4, HTR1B, HTR2A, KCNH2, MMP9, PTGS2 |
3.61125 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, HTR1D, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.60333 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, GRM1, HTR2A, HTR2B, HTR2C, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, SLC1A1, SLC6A3, SLC6A4, SRC, TERT, XDH |
3.60053 |
[BP] GO:0019725 |
cellular homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.59963 |
[BP] GO:0098810 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.5988 |
[BP] GO:0014062 |
None
|
HTR1A, HTR1B, SLC6A4 |
3.5988 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.5988 |
[BP] GO:0060359 |
None
|
CNR1, DRD2, DRD3, DRD4, HTR1B, SLC6A3 |
3.59143 |
[BP] GO:0045936 |
None
|
ADRA2A, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HTR1B, HTR1E, IGF1R, PPARA, PTPN1, XDH |
3.5798 |
[BP] GO:0010563 |
None
|
ADRA2A, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HTR1B, HTR1E, IGF1R, PPARA, PTPN1, XDH |
3.5733 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, CNR1, DRD2 |
3.57293 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB |
3.554 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
3.53737 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP4, FLT3, GRM1, GRM3, GRM5, HTR2A, HTR2B, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.5351 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.50398 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.48838 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, ALOX15, AXL, DRD2, DRD3, HTR1B, HTR2B, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
3.46523 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, DRD4, KCNH2, MMP9 |
3.44319 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD4, HTR1A, HTR2C, SLC6A2 |
3.43446 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.42391 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.42391 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD2, DRD3, DRD4, HTR1B, SLC6A3 |
3.42391 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DRD4, FLT3, GRM1, HTR2A, HTR2B, PIK3CB, PTPN1, SRC |
3.42164 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR1B, HTR2B |
3.40445 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, ESRRB, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SLC1A1, SLC6A3, SRC, TERT |
3.38863 |
[BP] GO:0001975 |
None
|
CNR2, DRD2, DRD3, DRD4 |
3.37842 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, MET, PIK3CA, PIK3CB, SRC, XDH |
3.35919 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA, RORC |
3.3562 |
[BP] GO:0072347 |
None
|
CNR1, DRD2, DRD3, HTR1B, SLC6A3 |
3.33536 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, DRD4, KCNH2, MMP9 |
3.30947 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AURKB, BCL2, CNR1, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
3.30777 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
3.30777 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
3.27075 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, CNR1, DRD2, DRD3, DRD4, HTR2B, HTR2C, MMP12, SRC |
3.27069 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, PIK3CB, SLC6A3, SRC, XDH |
3.26916 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.26107 |
[BP] GO:0055065 |
metal ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KCNH2, PIK3CB |
3.25909 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
3.25827 |
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
3.20648 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.20648 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.20034 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RORC, SLC6A4, SRC |
3.19252 |
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GRM3 |
3.17802 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD2, DRD3, PIK3CB, PTGS2 |
3.16905 |
[BP] GO:0002209 |
None
|
BCL2, DRD4, HTR1A, HTR2C |
3.15438 |
[BP] GO:0001662 |
None
|
BCL2, DRD4, HTR1A, HTR2C |
3.15438 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, AURKB, BCL2, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, XDH |
3.14956 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.14179 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.14179 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.12387 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.12387 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HTR2A, PTGS2, SLC6A3, TERT |
3.11406 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD4, ESR1, ESR2, FLT3, GRM1, GRM5, HTR2A, HTR2B, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TERT, XDH |
3.11406 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.10968 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.10968 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, DRD4, PTGS2 |
3.09764 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.09764 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.09625 |
[BP] GO:0042596 |
None
|
BCL2, DRD4, HTR1A, HTR2C |
3.05813 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, PIK3CA, SLC6A3 |
3.03825 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.03825 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, DRD3, ESR1, FABP4, KDR, MET, MMP12, PPARA, PTGS2, SLC6A3 |
3.03256 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB |
3.0278 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.02724 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
3.02724 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, DRD2, DRD4, GRM1, PIK3CA, PIK3CB, PTPN1, SRC |
3.02724 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, GRM5, HTR2A, PTPN1, SRC |
3.01143 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD2, HTR2A, MET, PIK3CA |
2.95379 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.92183 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
2.92048 |
[BP] GO:0007626 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM5, HTR2C, SLC6A3 |
2.92048 |
[BP] GO:0015872 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.91295 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.90875 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.90875 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.90875 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD2, DRD4, PTGS2 |
2.90693 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DRD4, FLT3, GRM1, HTR2A, HTR2B, IGF1R, PIK3CB, PTPN1, SRC |
2.90517 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, HSD11B2, HTR1A, HTR2C, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A4, SRC, TERT |
2.90517 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, CA2, CNR1, DRD2, DRD3, DRD4, HTR2B, HTR2C, MMP12, PTGS2, PTPN1, SRC |
2.88449 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD2, FLT3, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.8653 |
[BP] GO:1903531 |
None
|
ADORA1, ADRA2A, CNR1, DRD2, DRD3, DRD4, HTR1B |
2.86185 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, HTR5A, PTGS2, SLC6A4 |
2.85454 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, HTR2A, HTR2B, PIK3CA, PIK3CB, PTPN1, SRC, TERT, XDH |
2.85024 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.84023 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGS1, PTGS2 |
2.84023 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, DRD4, MMP9 |
2.83589 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.8303 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.82653 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.82653 |
[BP] GO:0033604 |
None
|
ADRA2A, CNR1, DRD2 |
2.82653 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.81233 |
[BP] GO:0014075 |
None
|
CNR2, DRD2, DRD3, DRD4 |
2.80119 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, DRD2, DRD3, GRM1, HTR2A, HTR2C, KCNH2, PTGS2, SLC1A1 |
2.79918 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2, TERT |
2.78984 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.7713 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.7713 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, CNR1, HTR2B, MET, PIK3CA, PPARA |
2.77035 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, CNR1, CYP19A1, DRD2, HTR1A, HTR2A, HTR2C |
2.77035 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9, TERT |
2.7644 |
[BP] GO:0003012 |
None
|
ADORA1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA |
2.76185 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, HSD11B2, PTGS2, SLC6A4, SRC, TYR |
2.75666 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.73945 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.73945 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SRC, TERT, XDH |
2.72586 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.71456 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC |
2.70208 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC |
2.70208 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.69873 |
[BP] GO:0035094 |
response to nicotine
|
BCL2, CNR1, DRD2, SLC6A3 |
2.69087 |
[BP] GO:0050890 |
None
|
ADORA1, CNR1, DRD2, DRD3, GRM5, HTR2A, PTGS2, SLC6A4 |
2.68355 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, DRD4, HTR2A, KCNH2, PTGS2 |
2.6701 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, RORC, SLC6A4 |
2.66502 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, HTR2A, HTR2B, HTR2C, KDR, PTPN1, SRC |
2.66415 |
[BP] GO:0051937 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.65892 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, DRD4, MMP9 |
2.65892 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HTR5A, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A3, SRC, TYR |
2.64568 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.63688 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC |
2.63688 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, GRM5, PTPN1 |
2.61937 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.60923 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD2, FLT3, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.60068 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIK3CB, PIM1, SRC, TYR |
2.58976 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, HTR1B, KCNH2, KDR, PTGS2, SRC |
2.58717 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, HTR2B, TERT |
2.58556 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.58398 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.58398 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.58398 |
[BP] GO:0051048 |
None
|
ADORA1, ADRA2A, CNR1, DRD2, DRD3, DRD4, HTR1B |
2.56513 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.56281 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, DRD2, HTR2A, KCNH2, PTGS2, SLC1A1 |
2.56281 |
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, HTR1A, SLC6A3, SLC6A4 |
2.55654 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.55654 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.55654 |
[BP] GO:0097366 |
None
|
CNR2, DRD2, DRD3, DRD4 |
2.55654 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
ADRA2A, CNR1, CNR2, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, IGF1R, MMP9, PTGS2, PTPN1, SRC |
2.54486 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.53742 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SRC, TERT, XDH |
2.53326 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, SLC6A3, SLC6A4 |
2.52343 |
[BP] GO:0006936 |
None
|
DRD2, HTR1D, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA |
2.52 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.52 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.52 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.52 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.52 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.52 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.52 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.52 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.52 |
[BP] GO:0050877 |
None
|
ADORA1, CNR1, CNR2, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, HTR2A, PTGS2, SLC6A3, SLC6A4, TYR |
2.51919 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, XDH |
2.51585 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.51585 |
[BP] GO:0043279 |
None
|
CNR1, DRD2, DRD3, HTR1B, SLC6A3 |
2.50797 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD3, GRM5, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PTPN1, SRC |
2.50695 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.50695 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, ESR1, FABP4, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC |
2.481 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC |
2.479 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR2B, MMP12, SLC6A4, SRC |
2.47828 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD2, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.46649 |
[BP] GO:0014821 |
None
|
DRD2, HTR1D, HTR2B |
2.46046 |
[BP] GO:0043112 |
None
|
ACHE, DRD2, DRD3, HTR1B, HTR2B |
2.43166 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.43166 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, CNR1, CSNK2A1, ESRRB, HTR2A, HTR2B, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1 |
2.42305 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.41182 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.40977 |
[BP] GO:0042053 |
None
|
DRD4, HTR1A, SLC6A3 |
2.39897 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.39897 |
[BP] GO:0042069 |
None
|
DRD4, HTR1A, SLC6A3 |
2.39897 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.39897 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A3, SLC6A4, SRC, TERT, XDH |
2.39323 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SRC, TERT, XDH |
2.38602 |
[BP] GO:0045934 |
None
|
ADRA2A, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HTR1B, HTR1E, MMP12, PPARA, RORC, SRC, TERT |
2.38444 |
[BP] GO:0022898 |
None
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.37992 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD2, HTR2A, KCNH2 |
2.37992 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, CNR1, PPARA |
2.3551 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, FLT3, GRM5, HTR2A, PTPN1, SRC |
2.34638 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.34584 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.33949 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, SRC |
2.33162 |
[BP] GO:0019233 |
None
|
CNR1, CNR2, GRM1, PTGS2 |
2.32951 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.32951 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CES1, CYP19A1, SLC6A3, TYR |
2.3231 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.3231 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FABP3, FABP4, MET, PIK3CA, PIK3CB |
2.32166 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, HSD11B2, PTGS2, SLC6A4, SRC, TYR |
2.3144 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA2A, DRD2, DRD3, GRM5, HTR2B, HTR5A, KDR |
2.31123 |
[BP] GO:0007611 |
None
|
CNR1, DRD2, DRD3, GRM5, HTR2A, PTGS2, SLC6A4 |
2.31123 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.28598 |
[BP] GO:0015844 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.28598 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.28598 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CNR1, CNR2, CYP19A1, DRD2, ESR1, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
2.28252 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.27828 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, HTR2B, TERT |
2.27828 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.2757 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.2757 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.2757 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2757 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.2757 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC |
2.27177 |
[BP] GO:0007613 |
None
|
CNR1, DRD2, HTR2A, PTGS2, SLC6A4 |
2.26619 |
[BP] GO:0008150 |
biological_process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR, XDH |
2.26504 |
[BP] GO:0032409 |
None
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.24978 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.2387 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, CNR1 |
2.2387 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.2325 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.2316 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, DRD2, MMP12, PPARA |
2.21957 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.21674 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.21674 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.20819 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, PTGS2, SLC6A4, SRC |
2.19324 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, CNR1, DRD2, DRD3, DRD4, HTR2B, MMP12, SRC |
2.19203 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.18993 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.18993 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.18993 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.18993 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.18993 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.18731 |
[BP] GO:0030168 |
platelet activation
|
ADRA2A, AXL, PIK3CA, PIK3CB, SRC |
2.18731 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.13687 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.13687 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SRC, TERT, TYR, XDH |
2.13687 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.11859 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, CNR2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.11859 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.10603 |
[BP] GO:0034762 |
None
|
ADRA2A, BCL2, CA2, DRD2, DRD3, DRD4, GRM5, KCNH2, MMP9 |
2.09141 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.08315 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.08315 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.08315 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.07414 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GRM5, HSD11B2, IGF1R, PPARA, PTGS2, SRC |
2.06199 |
[BP] GO:0060402 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.0596 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.04777 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.04777 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.04777 |
[BP] GO:0006693 |
None
|
CES2, PTGS1, PTGS2 |
2.04777 |
[BP] GO:0006692 |
None
|
CES2, PTGS1, PTGS2 |
2.04777 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.04048 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.01609 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA2A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, HTR1B, HTR2A, HTR2B, HTR2C, KCNH2, MMP12, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, XDH |
2.01177 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CA4, CNR1, CNR2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
12.1579 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CNR1, CNR2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
11.8474 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, ALOX15, AXL, CA2, CA4, CA9, CNR1, CNR2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PTGS2, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC |
10.4927 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT |
10.0692 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TYR |
7.92881 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR |
7.68184 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC |
6.21951 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CNR1, CNR2, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC |
5.08121 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA2A, CA2, CA4, CA9, CNR1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, MET, PTGS2, SLC1A1, SRC |
4.89467 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC |
4.89087 |
[CC] GO:0042734 |
None
|
CNR1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.37212 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CNR1, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SLC6A4, SRC |
4.17523 |
[CC] GO:0097458 |
None
|
ADORA1, CA2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, HTR5A, PTGS1, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC |
3.91208 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPL, AXL, CA12, CA14, CA4, CA9, CNR1, CNR2, DRD2, DRD3, DRD4, ESR1, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SLC6A4, TYR |
3.13582 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA2A, ALPL, AXL, CA12, CA14, CA9, CNR1, CNR2, DRD2, DRD3, DRD4, ESR1, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SLC6A4, TYR |
2.76731 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.69171 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.69171 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR, XDH |
2.65966 |
[CC] GO:0097060 |
None
|
CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.54639 |
[CC] GO:0045121 |
membrane raft
|
CNR1, HTR2A, KDR, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC |
2.50622 |
[CC] GO:0098857 |
membrane microdomain
|
CNR1, HTR2A, KDR, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC |
2.48742 |
[CC] GO:0098794 |
None
|
ADORA1, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
2.45189 |
[CC] GO:0043197 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.05883 |
[CC] GO:0044309 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.03172 |
[CC] GO:0098589 |
membrane region
|
CNR1, HTR2A, KDR, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC |
2.03017 |
[MF] GO:0030594 |
None
|
DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
20.083 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC6A3, SLC6A4 |
16.4015 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CNR1, CNR2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
16.2095 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.2095 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.2095 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.1864 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.1864 |
[MF] GO:0008227 |
None
|
ADRA2A, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.1954 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CNR1, CNR2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
14.8537 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, CNR1, CNR2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
14.415 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.7797 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, CNR1, CNR2, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
13.5197 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
11.6066 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CNR1, CNR2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
11.6066 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CNR1, CNR2, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
11.6066 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR, XDH |
10.8611 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
10.6524 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, TERT, TYR, XDH |
10.1457 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.94491 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA2A, CNR1, CNR2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
8.5283 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.97764 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
7.49687 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SLC6A3, SLC6A4, SRC |
6.94915 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.97562 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.65288 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD2, DRD3, DRD4, SLC6A3 |
5.37302 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC |
5.34183 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.09932 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
5.09756 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
4.90206 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.89087 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.89087 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TERT, TYR, XDH |
4.85866 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2, SRC |
4.7605 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
4.75331 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2, SRC |
4.53393 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.48293 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.46529 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
4.43015 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2, TYR |
4.21771 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.91208 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.79987 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.78061 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A3, SLC6A4, SRC |
3.67145 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, TERT, TYR, XDH |
3.60333 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.57293 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A3, SLC6A4, SRC |
3.56619 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, BCL2, CSNK2A1, DRD2, DRD4, ESR1, ESR2, FLT3, GRIK5, IGF1R, KCNH2, KDR, MET, MMP9, NQO2, PTGS2, SLC6A4, TERT, TYR, XDH |
3.5351 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.42391 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.42391 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.37842 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.31578 |
[MF] GO:0008504 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.27069 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.2047 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.17802 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SRC, TERT, XDH |
3.15756 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.14556 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.02724 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
2.91295 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.90875 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.90875 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.90875 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.90875 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
2.86185 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.74485 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.58556 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.52 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.52 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.52 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.52 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC |
2.48988 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, BCL2, DRD2, FLT3, KCNH2, NQO2, PTGS2, SLC6A4, TERT, TYR, XDH |
2.45233 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.39897 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.39897 |
[MF] GO:0005328 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.33949 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.33949 |
[MF] GO:0005326 |
None
|
SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
2.30447 |
[MF] GO:0015370 |
None
|
SLC1A1, SLC6A2, SLC6A3, SLC6A4 |
2.30447 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.2757 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.2757 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.2757 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SLC6A4, SRC, TERT, TYR, XDH |
2.26504 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.10057 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.08315 |
[MF] GO:0051380 |
None
|
ADRA2A, DRD4 |
2.08315 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, SRC |
2.0596 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.04777 |
[MF] GO:0099094 |
None
|
GRIA2, GRIA4, GRIK5, KCNH2 |
2.04048 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.00336 |